EMA guideline: no way...: [Design Issues]

posted by wienui  – Germany/Oman, 2019-12-09 06:25 (1156 d 09:54 ago) – Posting: # 20963
Views: 5,269

Dear Mittyri,

❝ I doubt that something exists at the moment.

❝ Please also see the related discussion and cites of EMA guideline.


Thank you very much, it is really helpful.

Best regards,

Osama

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
27 visitors (0 registered, 27 guests [including 9 identified bots]).
Forum time: 16:20 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5